Wendy Cross

CMC Matrix Leader, GSK

Wendy is a CMC Matrix Leader at GSK, where she is responsible for leading oligonucleotide projects through late phase development and into commercialisation.  Prior to taking this role, Wendy worked in a variety of technical roles where her main responsibility was the development of robust crystallisation processes for a broad range of small molecules at all phases of development.  She holds a PhD in inorganic chemistry/X-ray crystallography from the University of Manchester.

CPI's Medicines Manufacturing Innovation Centre (MMIC) and the National Manufacturing Institute Scotland (NMIS)

21 September 2023, GLASGOW